Maynard Um
-
-
-
-
-
-
-
INHIBRX reports interim data on colorectal cancer drug trial
-
-
-
-
-
-
-
Inhibrx, Inc. (INBX) Misses Q3 EPS by 71c
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Perform Rating on Inhibrx Biosciences (INBX)
-
-
-
-
-
402,467 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

